Titre : The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease
link : The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease
The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease
Conference Coverage from
The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD)
Progress in Fatty Liver and Pediatric Liver Disease
Damian McNamara
October 11, 2017
The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD)
Progress in Fatty Liver and Pediatric Liver Disease
Damian McNamara
October 11, 2017
WASHINGTON, DC — Advances in the treatment of nonalcoholic steatohepatitis (NASH) — including results from a phase 2 trial of a liver-targeted selective inhibitor of acetyl-CoA carboxylase — will be in the spotlight here at The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD).
Link
AASLD Website
The Liver Meeting
Abstract supplement for The Liver Meeting® 2017
Oral Abstracts and Posters
The Liver Meeting
Abstract supplement for The Liver Meeting® 2017
Oral Abstracts and Posters
Thus articles The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease
that is all articles The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease the link address https://newsaninpiration.blogspot.com/2017/10/the-liver-meeting-2017-progress-in.html
0 Response to "The Liver Meeting 2017: Progress in Fatty Liver and Pediatric Liver Disease"
Post a Comment